@Article{Rogala2020,
journal="Alergologia Polska - Polish Journal of Allergology",
issn="2353-3854",
volume="7",
number="2",
year="2020",
title="Biological therapy of asthma – position statement of Polish Allergology Society (PTA) and Polish Society of Lung Diseases (PTChP)",
abstract="Biological therapy is the breakthrough  in the management of spectrum of various diseases. It also concerns asthma therapy. The data regarding the role of biologics in the treatment strategy of severe asthma  are presented. The overview  on how mediators of type 2 inflammation drives the  pathology of the disease is given. It justifies the biological treatment options approved. The development of treatment strategy targeting non-type 2 inflammation is also highlighted. The data regarding the risk and safety of biologics are discussed. Document includes the featured rules of the classification of patients with severe asthma to this reliable and efficient  therapy. The outlook how to perceive the safety of biologics in the time of COVID-19 epidemic is also given.",
author="Rogala, Barbara
and Kupczyk, Maciej
and Bochenek, Grażyna
and Śliwiński, Paweł
and Moniuszko, Marcin
and Glück, Joanna
and Dobek, Rafał
and Kulus, Marek",
pages="64--80",
doi="10.5114/pja.2020.96664",
url="http://dx.doi.org/10.5114/pja.2020.96664"
}